# BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Urinary Incontinence in Postpartum and Early Post-Childbirth Women

> **NCT07413692** · NA · RECRUITING · sponsor: **BTL Industries Ltd.** · enrollment: 60 (estimated)

## Conditions studied

- Depressive Symptoms
- Urinary Incontinence

## Interventions

- **DEVICE:** EXOMIND (BTL-699-2) ActiveTreatment
- **DEVICE:** EMSELLA (HPM-6000UF) ActiveTreatment
- **DEVICE:** EXOMIND (BTL-699-2) Sham Treatment
- **DEVICE:** EMSELLA (HPM-6000UF) Sham Treatment

## Key facts

- **NCT ID:** NCT07413692
- **Lead sponsor:** BTL Industries Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-25
- **Primary completion:** 2026-12-11
- **Final completion:** 2026-12-11
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07413692

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07413692, "BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Urinary Incontinence in Postpartum and Early Post-Childbirth Women". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07413692. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*